Global Botulinum Toxin Market: Size, Trends and Forecasts Through 2018-2022, with Profiles for Allergan, Ipsen and Revance - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 2, 2019--The “Global Botulinum Toxin Market: Size, Trends and Forecasts (2018-2022 Edition)” report has been added to ResearchAndMarkets.com’s offering.
The global botulinum toxin market has increased at a significant annual growth rate in 2017 as compared to the preceding year 2016, and projections are made that the market will rise in the next five years i.e. 2018-2022 tremendously.
The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are: aging population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets.
Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.
Rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.
The competition in the global botulinum toxin market is stiff and dominated by big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
Key Topics Covered
1. Executive Summary
3. Global Market Analysis
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company ProfilesAllergan PLC Ipsen Revance Therapeutics Inc.
For more information about this report visit https://www.researchandmarkets.com/research/7zwq3n/global_botulinum?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005487/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/02/2019 12:12 PM/DISC: 01/02/2019 12:12 PM